INVESTORS & MEDIA
News Release
Regeneron Announces First Recipients of Annual "Regeneron Prize for Creative Innovation"
"We are excited to offer the Regeneron Prize for Creative Innovation to scientists who are beginning their research careers and show great promise," said
Regeneron is awarding two prizes for outstanding research this year.
- The Regeneron Prize for Creative Innovation by a Postdoctoral Fellow has been awarded to
Chuan Wu , Brigham andWomen's Hospital ,Harvard University . - The Regeneron Prize for Creative Innovation by a Graduate Student has been awarded to
Cody Gilleland ,Massachusetts Institute of Technology .
Additionally, this year Regeneron is recognizing two graduate student researchers with Honorable Mentions: Daria Zamolodchikov,
Requests for applicants were distributed to key academic institutions around the nation in February. Each institution was asked to nominate two graduate students and two postdoctoral fellows.
A key component of each application was a proposal, drafted by the nominee, explaining a "dream" project in biomedical research. This proposal gave the review committee at Regeneron insights into the nominee's creativity and ability to think independently as a scientist. Each nominee also included a curriculum vitae and list of publications; the trainee's productivity in his or her current laboratory also factored into the review committee's decision.
"We're looking for productive, creative, and innovative young scientists who are not afraid to think outside the box," said
Ten finalists were invited to Regeneron in April to meet with scientists, give presentations about their proposals, and tour the Company's facilities. The two winning trainees will each receive
"Regeneron is proud to support and encourage early career scientists as they forge their futures in biomedicine. To build the pipeline of promising new treatments for unmet medical needs, we must also develop the pipeline of talented new medical researchers," concluded Dr. Croll.
About
Regeneron is a leading science-based biopharmaceutical company based in
Contact Information:
Corporate Communications
914.847.7640
peter.dworkin@regeneron.com
SOURCE
News Provided by Acquire Media